Review



synergistic agents (sas)  (SAS institute)


Bioz Verified Symbol SAS institute is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    SAS institute synergistic agents (sas)
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents (Sas), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/synergistic+agents/pmc12205684-14-0-2
    Average 90 stars, based on 1 article reviews
    synergistic agents (sas) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy"

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2025.101928

    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Figure Legend Snippet: Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Techniques Used: Injection, Imaging, Irradiation

    Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: Irradiation, Staining, In Vivo

    In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.
    Figure Legend Snippet: In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Techniques Used: In Vivo, Microscopy, Staining, TUNEL Assay



    Similar Products

    90
    SAS institute synergistic agents (sas)
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents (Sas), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/synergistic+agents/pmc12205684-14-0-2
    Average 90 stars, based on 1 article reviews
    synergistic agents (sas) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    SAS institute synergistic agents
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/synergistic+agents/pmc11465552-5-4-5
    Average 90 stars, based on 1 article reviews
    synergistic agents - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Hengxing Group Co Ltd p-n synergistic flame retardant epoxy resin curing agent
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    P N Synergistic Flame Retardant Epoxy Resin Curing Agent, supplied by Hengxing Group Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/p+n+synergistic+flame+retardant+epoxy+resin+curing+agent/10__1002_slash_vnl__22017-174-94-96
    Average 90 stars, based on 1 article reviews
    p-n synergistic flame retardant epoxy resin curing agent - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    SAS institute hifu synergistic agents
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Hifu Synergistic Agents, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/synergistic+agents/pmc10188615-26-15-20
    Average 90 stars, based on 1 article reviews
    hifu synergistic agents - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    SAS institute synergistic agents based on biocompatible micro-/nanoparticles with some phase-change species
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents Based On Biocompatible Micro /Nanoparticles With Some Phase Change Species, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/synergistic+agents+based+on+biocompatible+micro++nanoparticles+with+some+phase+change+species/pmc09074192-7-20-12
    Average 90 stars, based on 1 article reviews
    synergistic agents based on biocompatible micro-/nanoparticles with some phase-change species - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    Selleck Chemicals synergistic agents
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents/Lapatinib/pmc06300392-206-33-36
    Average 96 stars, based on 1 article reviews
    synergistic agents - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: Injection, Imaging, Irradiation

    Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: Irradiation, Staining, In Vivo

    In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: In Vivo, Microscopy, Staining, TUNEL Assay